AC Immune acquires Parkinson’s disease vaccine candidate
28th July 2021 Uncategorised 0AC Immune is set to acquire Affiris’ entire portfolio of therapeutics targeting alpha-synuclein
More: AC Immune acquires Parkinson’s disease vaccine candidate
Source: News